RoslinCT and BlueRock Therapeutics Partner to Expand Access to Clinical-Grade Pluripotent Cell Lines for Cell Therapy ...
EDINBURGH, Scotland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 8, 2026-- RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization, today announced a strategic partnership with BlueRock Therapeutics, a leader in stem …